A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: CI-1033
Sponsor: Pfizer